Global Intravenous (IV) Therapy and Vein Access Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Intravenous (IV) Therapy and Vein Access Revenue
• 1.4 Market by Type
  • 1.4.1 Global Intravenous (IV) Therapy and Vein Access Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Infusion pumps
  • 1.4.3 Implantable Ports
  • 1.4.4 Intravenous Catheters
  • 1.4.5 Hypodermic Needles
  • 1.4.6 Other
• 1.5 Market by Application
  • 1.5.1 Global Intravenous (IV) Therapy and Vein Access Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Clinics
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Intravenous (IV) Therapy and Vein Access Market Perspective (2015-2026)
• 2.2 Global Intravenous (IV) Therapy and Vein Access Growth Trends by Regions
  • 2.2.1 Intravenous (IV) Therapy and Vein Access Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Intravenous (IV) Therapy and Vein Access Historic Market Share by Regions (2015-2020)
  • 2.2.3 Intravenous (IV) Therapy and Vein Access Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Intravenous (IV) Therapy and Vein Access Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Intravenous (IV) Therapy and Vein Access Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Intravenous (IV) Therapy and Vein Access Players by Market Size
  • 3.1.1 Global Top Intravenous (IV) Therapy and Vein Access Players by Revenue (2015-2020)
  • 3.1.2 Global Intravenous (IV) Therapy and Vein Access Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Intravenous (IV) Therapy and Vein Access Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Intravenous (IV) Therapy and Vein Access Market Concentration Ratio
  • 3.2.1 Global Intravenous (IV) Therapy and Vein Access Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Intravenous (IV) Therapy and Vein Access Revenue in 2019
• 3.3 Intravenous (IV) Therapy and Vein Access Key Players Head office and Area Served
• 3.4 Key Players Intravenous (IV) Therapy and Vein Access Product Solution and Service
• 3.5 Date of Enter into Intravenous (IV) Therapy and Vein Access Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Intravenous (IV) Therapy and Vein Access Historic Market Size by Type (2015-2020)
• 4.2 Global Intravenous (IV) Therapy and Vein Access Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)
• 5.2 Global Intravenous (IV) Therapy and Vein Access Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
• 6.2 Intravenous (IV) Therapy and Vein Access Key Players in North America (2019-2020)
• 6.3 North America Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
• 6.4 North America Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
• 7.2 Intravenous (IV) Therapy and Vein Access Key Players in Europe (2019-2020)
• 7.3 Europe Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
• 7.4 Europe Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

8 China

• 8.1 China Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
• 8.2 Intravenous (IV) Therapy and Vein Access Key Players in China (2019-2020)
• 8.3 China Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
• 8.4 China Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
• 9.2 Intravenous (IV) Therapy and Vein Access Key Players in Japan (2019-2020)
• 9.3 Japan Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
• 9.4 Japan Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
• 10.2 Intravenous (IV) Therapy and Vein Access Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
• 10.4 Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

11 India

• 11.1 India Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
• 11.2 Intravenous (IV) Therapy and Vein Access Key Players in India (2019-2020)
• 11.3 India Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
• 11.4 India Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
• 12.2 Intravenous (IV) Therapy and Vein Access Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
• 12.4 Central & South America Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 B. Braun
  • 13.1.1 B. Braun Company Details
  • 13.1.2 B. Braun Business Overview
  • 13.1.3 B. Braun Intravenous (IV) Therapy and Vein Access Introduction
  • 13.1.4 B. Braun Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020))
  • 13.1.5 B. Braun Recent Development
• 13.2 Baxter International
  • 13.2.1 Baxter International Company Details
  • 13.2.2 Baxter International Business Overview
  • 13.2.3 Baxter International Intravenous (IV) Therapy and Vein Access Introduction
  • 13.2.4 Baxter International Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
  • 13.2.5 Baxter International Recent Development
• 13.3 Becton Dickinson
  • 13.3.1 Becton Dickinson Company Details
  • 13.3.2 Becton Dickinson Business Overview
  • 13.3.3 Becton Dickinson Intravenous (IV) Therapy and Vein Access Introduction
  • 13.3.4 Becton Dickinson Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
  • 13.3.5 Becton Dickinson Recent Development
• 13.4 C. R. Bard
  • 13.4.1 C. R. Bard Company Details
  • 13.4.2 C. R. Bard Business Overview
  • 13.4.3 C. R. Bard Intravenous (IV) Therapy and Vein Access Introduction
  • 13.4.4 C. R. Bard Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
  • 13.4.5 C. R. Bard Recent Development
• 13.5 Fresenius Kabi
  • 13.5.1 Fresenius Kabi Company Details
  • 13.5.2 Fresenius Kabi Business Overview
  • 13.5.3 Fresenius Kabi Intravenous (IV) Therapy and Vein Access Introduction
  • 13.5.4 Fresenius Kabi Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
  • 13.5.5 Fresenius Kabi Recent Development
• 13.6 Hospira(ICU Medical)
  • 13.6.1 Hospira(ICU Medical) Company Details
  • 13.6.2 Hospira(ICU Medical) Business Overview
  • 13.6.3 Hospira(ICU Medical) Intravenous (IV) Therapy and Vein Access Introduction
  • 13.6.4 Hospira(ICU Medical) Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
  • 13.6.5 Hospira(ICU Medical) Recent Development
• 13.7 Medtronic
  • 13.7.1 Medtronic Company Details
  • 13.7.2 Medtronic Business Overview
  • 13.7.3 Medtronic Intravenous (IV) Therapy and Vein Access Introduction
  • 13.7.4 Medtronic Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
  • 13.7.5 Medtronic Recent Development
• 13.8 Smiths Group
  • 13.8.1 Smiths Group Company Details
  • 13.8.2 Smiths Group Business Overview
  • 13.8.3 Smiths Group Intravenous (IV) Therapy and Vein Access Introduction
  • 13.8.4 Smiths Group Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
  • 13.8.5 Smiths Group Recent Development
• 13.9 Teleflex
  • 13.9.1 Teleflex Company Details
  • 13.9.2 Teleflex Business Overview
  • 13.9.3 Teleflex Intravenous (IV) Therapy and Vein Access Introduction
  • 13.9.4 Teleflex Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
  • 13.9.5 Teleflex Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer